GENALICE, Knome Announce Partnership
By Bio-IT World Staff
January 12, 2015 | GENALICE and Knome today announced a strategic partnership to offer their products together as a turn-key solution for those using next-generation sequencing (NGS) data to interpret patients’ genomes.
GENALICE MAP is a fast and accurate preprocessing solution for aligning and calling NGS data. The tool seamlessly connects to Knome’s informatics and genomics interpretation system, the knoSYS platform.
Hans Karten, CEO of GENALICE, commented in a press release: “Whereas GENALICE MAP speeds up and improves the process of aligning and calling genomes, the knoSYS platform focuses on the annotation and interpretation piece. These two products complement each other beautifully in creating a workflow that eliminates many of the frustrations of wrangling NGS data today.”
In the same statement, Wolfgang Daum, CEO and President of Knome, said, “The GENALICE and Knome partnership came about in response to the reality that the amount of NGS data and its increasing usage requires processing and interpreting at an incredible pace. Wide-spread implementation of sequencing in the clinic toward the goal of precision medicine will only make this fact more apparent.”
Both products will still be offered separately.
Editors's Note: GENALICE will be exhibiting at the 2015 Bio-IT World Conference & Expo.
